Statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and aggregation: a systematic review and meta-analysis

Abstract Background Combination of statins and clopidogrel is frequently administered in patients with coronary artery disease (CAD). They are mainly activated and eliminated in the liver by cytochrome P450 isoenzyme 3A4 (CYP3A4). The aim was to clarify whether the coadministration of clopidogrel an...

Full description

Bibliographic Details
Main Authors: Ke An, Rong Huang, Sai Tian, Dan Guo, Jiaqi Wang, Hongyan Lin, Shaohua Wang
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Lipids in Health and Disease
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12944-019-1053-0
_version_ 1811288909718487040
author Ke An
Rong Huang
Sai Tian
Dan Guo
Jiaqi Wang
Hongyan Lin
Shaohua Wang
author_facet Ke An
Rong Huang
Sai Tian
Dan Guo
Jiaqi Wang
Hongyan Lin
Shaohua Wang
author_sort Ke An
collection DOAJ
description Abstract Background Combination of statins and clopidogrel is frequently administered in patients with coronary artery disease (CAD). They are mainly activated and eliminated in the liver by cytochrome P450 isoenzyme 3A4 (CYP3A4). The aim was to clarify whether the coadministration of clopidogrel and statins attenuate respective efficacy. Methods PubMed, Embase, the Cochrane Library, Web of Science and Clinical Trials. gov were searched for until August 2018. Randomized controlled trials (RCTs) and cohort studies were taken into quality evaluation. Data were pooled using random effect models to estimate standard mean difference (SMD) or risk ratio (RR) with 95% confidence interval (CI). Results In total, 28 studies representing 25,267 participants were included. Statins reduce the mortality of patients administered clopidogrel (RR 0.54; 95% CI 0.40,0.74; p = 0.000), no differences were found in platelet aggregation (PA) (SMD 0.02; 95% CI -0.38,0.42; p = 0.920) and the expressions of P-selectin (SMD -0.04; 95% CI -0.14,0.05; p = 0.346), CD40L (SMD 0.09; 95% CI -0.29,0.48; p = 0.633), CD63 (SMD 0.09; 95% CI -0.01,0.19; p = 0.079) and PAC-1 (SMD 0.03; 95% CI -0.08,0.13; p = 0.633). Furthermore, CYP3A4 metabolized or non-CYP3A4 metabolized statins have no discrepancies in PA (SMD 0.13; 95% CI -0.31,0.58; p = 0.556), P-selectin (SMD 0.17; 95% CI -0.16,0.51; p = 0310), death (RR 0.89; 95% CI 0.38,2.07; p = 0.791), except for triglyceride (TG) (SMD -0.19; 95% CI –0.33,-0.06; p = 0.005). Conclusions This meta-analysis confirmed that statins reduce mortality in patients undergoing clopidogrel treatment without affecting platelet activation and aggregation.
first_indexed 2024-04-13T03:45:49Z
format Article
id doaj.art-6e414be5e0f94d0fa7cfc6ef12ce2f04
institution Directory Open Access Journal
issn 1476-511X
language English
last_indexed 2024-04-13T03:45:49Z
publishDate 2019-05-01
publisher BMC
record_format Article
series Lipids in Health and Disease
spelling doaj.art-6e414be5e0f94d0fa7cfc6ef12ce2f042022-12-22T03:04:01ZengBMCLipids in Health and Disease1476-511X2019-05-0118111110.1186/s12944-019-1053-0Statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and aggregation: a systematic review and meta-analysisKe An0Rong Huang1Sai Tian2Dan Guo3Jiaqi Wang4Hongyan Lin5Shaohua Wang6Department of Endocrinology, Affiliated Zhongda Hospital of Southeast UniversityDepartment of Endocrinology, Affiliated Zhongda Hospital of Southeast UniversityDepartment of Endocrinology, Affiliated Zhongda Hospital of Southeast UniversityDepartment of Endocrinology, Affiliated Zhongda Hospital of Southeast UniversityDepartment of Endocrinology, Affiliated Zhongda Hospital of Southeast UniversityDepartment of Endocrinology, Affiliated Zhongda Hospital of Southeast UniversityDepartment of Endocrinology, Affiliated Zhongda Hospital of Southeast UniversityAbstract Background Combination of statins and clopidogrel is frequently administered in patients with coronary artery disease (CAD). They are mainly activated and eliminated in the liver by cytochrome P450 isoenzyme 3A4 (CYP3A4). The aim was to clarify whether the coadministration of clopidogrel and statins attenuate respective efficacy. Methods PubMed, Embase, the Cochrane Library, Web of Science and Clinical Trials. gov were searched for until August 2018. Randomized controlled trials (RCTs) and cohort studies were taken into quality evaluation. Data were pooled using random effect models to estimate standard mean difference (SMD) or risk ratio (RR) with 95% confidence interval (CI). Results In total, 28 studies representing 25,267 participants were included. Statins reduce the mortality of patients administered clopidogrel (RR 0.54; 95% CI 0.40,0.74; p = 0.000), no differences were found in platelet aggregation (PA) (SMD 0.02; 95% CI -0.38,0.42; p = 0.920) and the expressions of P-selectin (SMD -0.04; 95% CI -0.14,0.05; p = 0.346), CD40L (SMD 0.09; 95% CI -0.29,0.48; p = 0.633), CD63 (SMD 0.09; 95% CI -0.01,0.19; p = 0.079) and PAC-1 (SMD 0.03; 95% CI -0.08,0.13; p = 0.633). Furthermore, CYP3A4 metabolized or non-CYP3A4 metabolized statins have no discrepancies in PA (SMD 0.13; 95% CI -0.31,0.58; p = 0.556), P-selectin (SMD 0.17; 95% CI -0.16,0.51; p = 0310), death (RR 0.89; 95% CI 0.38,2.07; p = 0.791), except for triglyceride (TG) (SMD -0.19; 95% CI –0.33,-0.06; p = 0.005). Conclusions This meta-analysis confirmed that statins reduce mortality in patients undergoing clopidogrel treatment without affecting platelet activation and aggregation.http://link.springer.com/article/10.1186/s12944-019-1053-0ClopidogrelStatinsMeta-analysisMortalityPlatelet aggregationLipid
spellingShingle Ke An
Rong Huang
Sai Tian
Dan Guo
Jiaqi Wang
Hongyan Lin
Shaohua Wang
Statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and aggregation: a systematic review and meta-analysis
Lipids in Health and Disease
Clopidogrel
Statins
Meta-analysis
Mortality
Platelet aggregation
Lipid
title Statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and aggregation: a systematic review and meta-analysis
title_full Statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and aggregation: a systematic review and meta-analysis
title_fullStr Statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and aggregation: a systematic review and meta-analysis
title_full_unstemmed Statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and aggregation: a systematic review and meta-analysis
title_short Statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and aggregation: a systematic review and meta-analysis
title_sort statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and aggregation a systematic review and meta analysis
topic Clopidogrel
Statins
Meta-analysis
Mortality
Platelet aggregation
Lipid
url http://link.springer.com/article/10.1186/s12944-019-1053-0
work_keys_str_mv AT kean statinssignificantlyreducemortalityinpatientsreceivingclopidogrelwithoutaffectingplateletactivationandaggregationasystematicreviewandmetaanalysis
AT ronghuang statinssignificantlyreducemortalityinpatientsreceivingclopidogrelwithoutaffectingplateletactivationandaggregationasystematicreviewandmetaanalysis
AT saitian statinssignificantlyreducemortalityinpatientsreceivingclopidogrelwithoutaffectingplateletactivationandaggregationasystematicreviewandmetaanalysis
AT danguo statinssignificantlyreducemortalityinpatientsreceivingclopidogrelwithoutaffectingplateletactivationandaggregationasystematicreviewandmetaanalysis
AT jiaqiwang statinssignificantlyreducemortalityinpatientsreceivingclopidogrelwithoutaffectingplateletactivationandaggregationasystematicreviewandmetaanalysis
AT hongyanlin statinssignificantlyreducemortalityinpatientsreceivingclopidogrelwithoutaffectingplateletactivationandaggregationasystematicreviewandmetaanalysis
AT shaohuawang statinssignificantlyreducemortalityinpatientsreceivingclopidogrelwithoutaffectingplateletactivationandaggregationasystematicreviewandmetaanalysis